KEVIN GAREY to Health Care Costs
This is a "connection" page, showing publications KEVIN GAREY has written about Health Care Costs.
Connection Strength
1.357
-
Economic health care costs of blood culture contamination: A systematic review. Am J Infect Control. 2019 08; 47(8):963-967.
Score: 0.514
-
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J Hosp Infect. 2016 Jul; 93(3):286-9.
Score: 0.422
-
Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther. 2006 Aug; 28(8):1208-1216.
Score: 0.215
-
High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. J Hosp Infect. 2011 Sep; 79(1):23-6.
Score: 0.076
-
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010 Apr; 74(4):309-18.
Score: 0.069
-
Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery. Pharmacotherapy. 2008 Jun; 28(6):699-706.
Score: 0.061